'Pharmaceutical science' diaporamas de présentation

III. Academic Committee Meeting

III. Academic Committee Meeting. October 26, 2012. Cynthia Moten Associate Director, Academic Affairs. Agenda item no. 9 DOCTOR OF NURSING PRACTICE OVERVIEW. Doctor of Nursing Practice Overview.

618 views • 50 slides

Annual Teachers Seminar, Monash University June 2011

409 views • 32 slides

Annual Teachers Seminar, Monash University June 2011

Annual Teachers Seminar, Monash University June 2011. Educating tomorrow’s pharmacy and pharmaceutical science leaders Peter Stewart Deputy Dean Faculty of Pharmacy and Pharmaceutical Sciences. What are we going to do?. the faculty a day in the life of a student – educational technology

457 views • 32 slides

PTIT for DCU of OINDP: Approaches to Resolution of Identified Issues

PTIT for DCU of OINDP: Approaches to Resolution of Identified Issues. Wallace P. Adams, Ph.D. OPS/IO Advisory Committee for Pharmaceutical Science 21 October 2003 Rockville, MD. Outline. Current DCU and SCU Tests Parametric Tolerance Interval Test (PTIT) Consensus Points OPS Issues

517 views • 25 slides

Regulatory Issues Related to Crystal Habits - Polymorphism

465 views • 16 slides

Electronic Diaries: Impact on Drug Development

Electronic Diaries: Impact on Drug Development. Saul Shiffman, Ph.D. Chief Science Officer invivodata, inc. Advisory Committee for Pharmaceutical Science 19-20 October, 2004. Outline. 25% of clinical trials use patient diaries Paper diaries Slow completion of clinical trials

406 views • 16 slides

FDA Regulation of Drug Quality: New Challenges

FDA Regulation of Drug Quality: New Challenges. Janet Woodcock, M.D. Director, Center for Drug Evaluation and Research, Food and Drug Administration November 16, 2001. Regulation of Drug Quality: Current Status. Pharmaceutical industry manufacturing sector highly regulated

382 views • 14 slides

Advisory Committee for Pharmaceutical Science Rockville, MD November 28 and 29, 2001

Advisory Committee for Pharmaceutical Science Rockville, MD November 28 and 29, 2001. Introduction. Helen N. Winkle Acting Director Office of Pharmaceutical Science Center for Drug Evaluation and Research Food and Drug Administration. Office of Pharmaceutical Science.

391 views • 11 slides

Welcome and Introduction to the Meeting

227 views • 11 slides

Sponsored by Large Event Funding

124 views • 3 slides